QA: Johnson Johnson in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2024_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 53,495,000,000
1 IntangibleAssetsNetIncludingGoodwill 70,733,000,000
2 PropertyPlantAndEquipmentNet 19,898,000,000
3 remainder_Assets 23,432,000,000
4 LiabilitiesCurrent 46,282,000,000
5 LiabilitiesNoncurrent 39,279,000,000
6 remainder_Liabilities 13,223,000,000
7 CostOfGoodsAndServicesSold 26,567,972,245
8 SellingGeneralAndAdministrativeExpense 21,625,929,318
9 ResearchAndDevelopmentExpense 15,109,902,604
10 remainder_Expenses 3,313,857,585
11 remainder_Revenues 85,299,718,792
12 remainder_NetIncome 100,240,240,122
13 remainder_ComprehensiveNetIncome -3,677,499,686
  yvar yval
0 Assets 167,558,000,000
1 Liabilities 98,784,000,000
2 Expenses 66,617,661,752
3 Revenues 85,299,718,792
4 StockholdersEquity 68,774,000,000
5 NetIncome 118,922,297,162
6 ComprehensiveNetIncome 117,083,547,319
7 BaseVar 261,088,560,176
8 EconomicCapitalRatiobeforeLimitedLiability 2.01
9 EconomicCapitalRatio 3.03

Edgar->Model Mapping

Feature Distribution

Change over Time